Related Experiment Videos
Hyperproinsulinaemia in impaired glucose tolerance
1Diabetic Clinic, General Hospital, Birmingham, U.K.
Clinical Science (London, England : 1979)
|July 1, 1993
Summary
Newly diagnosed impaired glucose tolerance in non-obese individuals is linked to elevated fasting proinsulin levels. This suggests a potential defect in islet B cell proinsulin processing, impacting glucose regulation.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Research
Background:
- Impaired glucose tolerance (IGT) is a precursor to type 2 diabetes.
- Understanding early molecular markers in IGT is crucial for timely intervention.
- Islet B cell function and proinsulin processing are key in glucose homeostasis.
Purpose of the Study:
- To investigate basal circulating concentrations of islet B cell products in non-obese subjects with newly diagnosed IGT.
- To compare proinsulin and C-peptide levels between IGT subjects and healthy controls.
Main Methods:
- Two-site monoclonal antibody-based immunoradiometric assays were used for measurements.
- Fasting plasma samples were collected after a 10-hour overnight fast.
- Subjects with newly diagnosed IGT were compared to age- and BMI-matched healthy controls.
Main Results:
- Fasting blood glucose and C-peptide levels did not differ significantly between groups.
- Fasting concentrations of intact proinsulin were significantly higher (nearly four-fold) in the IGT group.
- Fasting concentrations of 32-33 split proinsulin were also elevated (almost double) in the IGT group.
Conclusions:
- Elevated fasting proinsulin-like molecules are observed in non-obese individuals with newly diagnosed IGT.
- These findings suggest a defect in islet B cell proinsulin processing in individuals with IGT.
- This defect may contribute to the pathophysiology of impaired glucose tolerance.